Erratum in: “SZN-413, a FZD4 Agonist, as a Potential Novel Therapeutic for the Treatment of Diabetic Retinopathy” by Huy Nguyen, Hui Chen, Meghah Vuppalapaty, Elizabeth Whisler, Kelsey Ronarda Logas, Parthasarathy Sampathkumar, Russell Byron Fletcher, Asmiti Sura, Nicholas Suen, Suhani Gupta, Tom Lopez, Jay Ye, Shengjiang Tu, Menaka Bolaki, Wen-Chen Yeh, Yang Li, and Sung-Jin Lee (
Transl Vis Sci Technol. 2022;11(9):19),
https://doi.org/10.1167/tvst.11.9.19.
Due to publisher error, the Disclosure in the Acknowledgments was incomplete when the article was first published. The Disclosure has now been updated in the article online.